Table 3 Characteristics of the included clinical trial study protocols for lower extremity endovascular interventions for the treatment of PAD
From: Diversity in randomized clinical trials for peripheral artery disease: a systematic review
Trial Name and Clinical Trial ID No. | Protocol accessible | Year of protocol publication | Method of recruitment | Information on barriers to transportation available | How transportation barriers were addressed? | Patient navigation/ coaching strategies adopted | Cultural competency training for clinical research associates | Relationship building/social marketing | Strategies for follow-up |
|---|---|---|---|---|---|---|---|---|---|
EMINENT NCT02921230 | Yes | 2019 | Clinics/Hospitals | Yes | Travel expenses | NR | NR | NR | Telephone; Office /clinic visits |
LIMES NCT04772300 | Yes | 2022 | NR | No | NR | NR | NR | NR | NR |
SIRONA NCT04475783 | Yes | 2021 | Clinics/Hospitals | No | NR | NR | NR | NR | Telephone; Office /clinic visits; letter |
SirPAD NCT04238546 | Yes | 2022 | Other: Academic, Clinics/Hospitals | Yes | NR | NR | NR | NR | Telephone; Office /clinic visits |
Lutonix BTK Trial NCT01870401 | Yes | 2017 | NR | No | NR | NR | NR | NR | Telephone; Office /clinic visits |
SFA ISR NCT02063672 | Yes | 2016 | Clinics/Hospitals | No | NR | NR | NR | NR | Telephone; Office /clinic visits |
BIOPACT-RCT NCT03884257 | Yes | 2022 | NR | No | NR | NR | NR | NR | Unknown |
RANGER II SFA NCT03064126 | Yes | 2018 | Clinics/Hospitals | Yes | Stipend | NR | NR | NR | Telephone; Office /clinic visits |
IMPERIAL NCT02574481 | Yes | 2016 | Clinics/Hospitals | Yes | Travel expenses | NR | NR | NR | Telephone; Office /clinic visits |
TRANSCEND NCT03241459 | Yes | 2019 | Clinics/Hospitals | No | NR | NR | NR | NR | NR |